Hongyu Chen
Research Subjects
Research Interests
Hongyu Chen has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Lan Yu
Children’s Hospital, Zhejiang University School of Medicine Children's Hospital, National Clinical Research Center for Child Health
2 shared publications - Xianghong Zhang
Department of Cardiac Intensive Care Uni Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases Zhejiang Hangzhou China
2 shared publications Fengxia Li
Zhejiang Key Laboratory of Neonatal Diseases Hangzhou Zhejiang China
1 shared publicationQiang Shu
Department of Cardiac Surgery Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health Zhejiang Hangzhou China
1 shared publicationShanshan Shi
Department of Cardiac Intensive Care Unit Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health Zhejiang Hangzhou China
1 shared publicationTingting Wen
Department of Anesthesiology The First Affiliated Hospital, Zhejiang University School of Medicine Zhejiang Hangzhou China
1 shared publication
Latest Publications
- 12 October 2026
- Published by Wiley in American Journal of Medical Genetics Part A
Novel Compound Heterozygous ATAD3A Variants in Harel‐Yoon Syndrome With Congenital Cataracts and Dilated Cardiomyopathy
Harel‐Yoon syndrome is a rare mitochondrial disorder caused by pathogenic variants in ATAD3A , typically characterized by neonatal respiratory insufficiency, cataracts, developmental delay, hypotonia, and cerebellar atrophy. We report a pediatric patient with compound heterozygous missense variants in ATAD3A (c.655C>T, p.R219C and c.980G>C, p.R327P) who presented with an atypical phenotype manifested as early‐onset congenital cataracts and progressive dilated cardiomyopathy. Notably the patient did not show typical neurological manifestations nor the cardiac presentations of hypertrophic cardiomyopathy. The maternally inherited c.655C>T variant was absent from population databases, while paternally inherited c.980G>C was previously associated with Harel‐Yoon syndrome. In silico protein structure modeling demonstrated that the mutant ATAD3A hexamer showed a looser and more disorganized conformation compared to that of the wild‐type, suggesting functional impairment. This case expands the phenotypic spectrum of ATAD3A ‐related disorders and highlights the importance of long‐term surveillance in patients with ATAD3A variants, even in the absence of classical neurological features. In addition, our findings support the inclusion of ATAD3A in the genetic differential diagnosis for patients with congenital cataracts and cardiomyopathy.
- 12 October 2026
- Published by Wiley in American Journal of Medical Genetics Part A
Novel Compound Heterozygous ATAD3A Variants in Harel‐Yoon Syndrome With Congenital Cataracts and Dilated Cardiomyopathy
Harel‐Yoon syndrome is a rare mitochondrial disorder caused by pathogenic variants in ATAD3A , typically characterized by neonatal respiratory insufficiency, cataracts, developmental delay, hypotonia, and cerebellar atrophy. We report a pediatric patient with compound heterozygous missense variants in ATAD3A (c.655C>T, p.R219C and c.980G>C, p.R327P) who presented with an atypical phenotype manifested as early‐onset congenital cataracts and progressive dilated cardiomyopathy. Notably the patient did not show typical neurological manifestations nor the cardiac presentations of hypertrophic cardiomyopathy. The maternally inherited c.655C>T variant was absent from population databases, while paternally inherited c.980G>C was previously associated with Harel‐Yoon syndrome. In silico protein structure modeling demonstrated that the mutant ATAD3A hexamer showed a looser and more disorganized conformation compared to that of the wild‐type, suggesting functional impairment. This case expands the phenotypic spectrum of ATAD3A ‐related disorders and highlights the importance of long‐term surveillance in patients with ATAD3A variants, even in the absence of classical neurological features. In addition, our findings support the inclusion of ATAD3A in the genetic differential diagnosis for patients with congenital cataracts and cardiomyopathy.
- 17 August 2025
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (1) , 199-204
Novel Compound Heterozygous Missense Variants in RPL3L Gene Associated With Neonatal Dilated Cardiomyopathy
Dilated cardiomyopathy type 2D (CMD2D) is a rare autosomal recessive disorder characterized by neonatal‐onset severe cardiomyopathy, rapid progression to cardiac decompensation, and high mortality, with heart transplantation being the only life‐saving intervention. Although mutations in RPL3L , a muscle‐specific ribosomal protein gene critical for cardiac and skeletal muscle function, are known to cause CMD2D, this disorder remains genetically and clinically undercharacterized. To date, only 13 patients with RPL3L ‐related CMD2D have been reported, with nearly all of whom are attributed to compound missense mutations. Using whole exome sequencing, we identified an infant with fulminant DCM and severe acute heart failure who carried compound heterozygous RPL3L variants: c.346C>T (p.R116C) and c.605A>G (p.E202G). Histopathological analysis revealed cardiomyocyte death, collagen deposition, disturbed mitochondrial structure, and deregulated sarcomeres. Computational protein modeling demonstrated these mutations induce conformational changes in RPL3L, suggesting potential functional relevance. This case expands the mutational spectrum of CMD2D and emphasizes the need for further genotype–phenotype correlations to elucidate the pathogenesis of this lethal disorder.
- 17 August 2025
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (1) , 199-204
Novel Compound Heterozygous Missense Variants in RPL3L Gene Associated With Neonatal Dilated Cardiomyopathy
Dilated cardiomyopathy type 2D (CMD2D) is a rare autosomal recessive disorder characterized by neonatal‐onset severe cardiomyopathy, rapid progression to cardiac decompensation, and high mortality, with heart transplantation being the only life‐saving intervention. Although mutations in RPL3L , a muscle‐specific ribosomal protein gene critical for cardiac and skeletal muscle function, are known to cause CMD2D, this disorder remains genetically and clinically undercharacterized. To date, only 13 patients with RPL3L ‐related CMD2D have been reported, with nearly all of whom are attributed to compound missense mutations. Using whole exome sequencing, we identified an infant with fulminant DCM and severe acute heart failure who carried compound heterozygous RPL3L variants: c.346C>T (p.R116C) and c.605A>G (p.E202G). Histopathological analysis revealed cardiomyocyte death, collagen deposition, disturbed mitochondrial structure, and deregulated sarcomeres. Computational protein modeling demonstrated these mutations induce conformational changes in RPL3L, suggesting potential functional relevance. This case expands the mutational spectrum of CMD2D and emphasizes the need for further genotype–phenotype correlations to elucidate the pathogenesis of this lethal disorder.